295 related articles for article (PubMed ID: 21622185)
1. WT1/EGR1-mediated control of STIM1 expression and function in cancer cells.
Ritchie MF; Zhou Y; Soboloff J
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2402-15. PubMed ID: 21622185
[TBL] [Abstract][Full Text] [Related]
2. Wilms tumor suppressor 1 (WT1) and early growth response 1 (EGR1) are regulators of STIM1 expression.
Ritchie MF; Yue C; Zhou Y; Houghton PJ; Soboloff J
J Biol Chem; 2010 Apr; 285(14):10591-6. PubMed ID: 20123987
[TBL] [Abstract][Full Text] [Related]
3. STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion.
Motiani RK; Hyzinski-García MC; Zhang X; Henkel MM; Abdullaev IF; Kuo YH; Matrougui K; Mongin AA; Trebak M
Pflugers Arch; 2013 Sep; 465(9):1249-60. PubMed ID: 23515871
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
6. Wilms tumor 1 gene, CD97, and the emerging biogenetic profile of glioblastoma.
Somasundaram A; Ardanowski N; Opalak CF; Fillmore HL; Chidambaram A; Broaddus WC
Neurosurg Focus; 2014 Dec; 37(6):E14. PubMed ID: 25434383
[TBL] [Abstract][Full Text] [Related]
7. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
10. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
11. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
[TBL] [Abstract][Full Text] [Related]
12. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
13. Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
Busch M; Schwindt H; Brandt A; Beier M; Görldt N; Romaniuk P; Toska E; Roberts S; Royer HD; Royer-Pokora B
Hum Mol Genet; 2014 Aug; 23(15):3958-74. PubMed ID: 24619359
[TBL] [Abstract][Full Text] [Related]
14. RNA binding by the Wilms tumor suppressor zinc finger proteins.
Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
[TBL] [Abstract][Full Text] [Related]
15. The role of WT1 in oncogenesis: tumor suppressor or oncogene?
Loeb DM; Sukumar S
Int J Hematol; 2002 Aug; 76(2):117-26. PubMed ID: 12215009
[TBL] [Abstract][Full Text] [Related]
16. A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16.
Kim MK; Mason JM; Li CM; Berkofsky-Fessler W; Jiang L; Choubey D; Grundy PE; Tycko B; Licht JD
Neoplasia; 2008 Jan; 10(1):69-78. PubMed ID: 18231640
[TBL] [Abstract][Full Text] [Related]
17. In silico regulatory analysis for exploring human disease progression.
Holloway DT; Kon M; DeLisi C
Biol Direct; 2008 Jun; 3():24. PubMed ID: 18564415
[TBL] [Abstract][Full Text] [Related]
18. A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells.
Sakakini N; Turchi L; Bergon A; Holota H; Rekima S; Lopez F; Paquis P; Almairac F; Fontaine D; Baeza-Kallee N; Van Obberghen-Schilling E; Junier MP; Chneiweiss H; Figarella-Branger D; Burel-Vandenbos F; Imbert J; Virolle T
J Biol Chem; 2016 May; 291(20):10684-99. PubMed ID: 27002148
[TBL] [Abstract][Full Text] [Related]
19. WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.
Netinatsunthorn W; Hanprasertpong J; Dechsukhum C; Leetanaporn R; Geater A
BMC Cancer; 2006 Apr; 6():90. PubMed ID: 16606472
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.
Keating GL; Reid HM; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
